Skip to main content
OpenTrials
Completed

NCT Number: NCT00284271

Feasibility and Efficacy of BACOPP-21 for Patients > 60 Years With Intermediate or Advanced Hodgkins Lymphoma

This study is designed to test (1) feasibility and efficiancy of new BACOPP regimen and (2) toxicity, overall response and FFTF.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hodgkin´s Lymphoma

Age range

61 year–75 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

University of Cologne

Cologne, 50931, Germany

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Hodgkin´s lymphoma (histologically proven)
  • CS (PS) I and II with one of the risk factors a-d
  • bulky mediastinal mass (> 1/3 maximum transverse thorax diameter)
  • extranodal involvement
  • ESR > 50 (A), > 30 (B-symptoms)
  • 3 or more lymph node areas involved
  • CS (PS) III and IV
  • Written informed consent

Exclusion criteria

  • Leukocytes <3000/microl
  • Platelets <100000/microl
  • Hodgkin´s Disease as "composite lymphoma"
  • Activity index (WHO) < grade 2

Treatment and study plan

Cyclophosphamide

Drug

Adramycin

Drug

Procarbacine

Drug

Prednisone

Drug

Vincristine

Drug

Bleomycin

Drug

Erythropoietin beta

Drug

Sponsors and collaborators

Lead sponsor

University of Cologne

Other

Registry information

Important dates

Study start
2004
Primary completion
2005
First posted
Jan 31, 2006
Registry last updated
Jul 29, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.